jueves, 13 de junio de 2013

NCHHSTP Newsroom: A Daily Dose of HIV Medication Reduces Infection Risk among People Who Inject Drugs

NCHHSTP Newsroom: A Daily Dose of HIV Medication Reduces Infection Risk among People Who Inject Drugs

NCHHSTP Newsroom: A Daily Dose of HIV Medication Reduces Infection Risk among People Who Inject Drugs

You are subscribed to NCHHSTP Newsroom from the Centers for Disease Control and Prevention (CDC).
A daily dose of a medication used to treat HIV infection – a prevention strategy known as pre-exposure prophylaxis (PrEP) – reduced the risk of infection among people who inject drugs by 49 percent according to a new study announced today. Those who took the medication most consistently had even higher levels of protection – in this group, risk was reduced by over 70 percent.
The findings were published online today in the Lancet. CDC also published interim guidance for providers who wish to prescribe PrEP to people who inject drugs in this week's Morbidity and Mortality Weekly Report.
For more information, please see our press release and fact sheet. You may also want to visit the NCHHSTP newsroom.

No hay comentarios:

Publicar un comentario